Shandong Lukang Pharmaceutical (600789.SS) Earnings Analysis
Shandong Lukang Pharmaceutical (600789.SS) has no confirmed upcoming earnings date. Trailing P/E 42.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600789.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600789.SS. This page updates as the calendar is published.
600789.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | 0.03233 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.09 CNY | n/a | n/a | n/a |
| 2024-09-29 | 0.05241 CNY | n/a | n/a | n/a |
600789.SS valuation and analyst view
| Trailing P/E | 42.97 |
|---|---|
| Trailing EPS | 0.16179 CNY |
| Price / book | 1.49 |
| Dividend yield | 0.68% |
| Market cap | 6.54B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shandong Lukang Pharmaceutical (600789.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600789.SS. This page updates as the calendar is published.
Did 600789.SS beat earnings last quarter?
Consensus estimate data was not available for 600789.SS's 2025-06-30 report.
What is 600789.SS's current P/E ratio and EPS?
600789.SS trades at a trailing P/E of 42.97 on trailing EPS of 0.1617938920962102 CNY.
What do analysts rate 600789.SS?
600789.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.